Dr. Michael X. Pham, M.D.
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- University of California, San Francisco School of Medicine (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 221
Licensed in California since 2000, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: University of California, San Francisco School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
CA license A71816 (first issued 2000; current) -
Cardiovascular Disease Physician
CA license A71816 (first issued 2000; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- California PAcific Medical Center- Van Ness Campus San Francisco, CA
- Alta Bates Summit Medical Center - Alta Bates Camp Berkeley, CA
- California PAcific Medical Ctr-Davies Campus Hosp San Francisco, CA
- California PAcific Medical Center - Mission Bernal San Francisco, CA
- Sutter Santa Rosa Regional Hospital Santa Rosa, CA
Medical groups
- Sutter Bay Medical Foundation (3,829 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 221
- Services billed
- 1,714
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 284 | 45 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 277 | 59 |
| Evaluation of lower heart chamber assist device | 241 | 34 |
| Established patient office or other outpatient visit, 40-54 minutes | 147 | 90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 76 | 70 |
| Established patient office or other outpatient visit, 30-39 minutes | 42 | 30 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 30 | 28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | 20 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carvedilol Other prescribers in San Francisco, CA | 132 |
| Entresto (sacubitril/valsartan) Other prescribers in San Francisco, CA | 128 |
| Atorvastatin Calcium Other prescribers in San Francisco, CA | 111 |
| Spironolactone Other prescribers in San Francisco, CA | 81 |
| Farxiga (dapagliflozin propanediol) Other prescribers in San Francisco, CA | 80 |
| Eliquis (apixaban) Other prescribers in San Francisco, CA | 71 |
| Bumetanide Other prescribers in San Francisco, CA | 67 |
| Metoprolol Succinate Other prescribers in San Francisco, CA | 45 |
| Vyndamax (tafamidis) | 45 |
| Jardiance (empagliflozin) Other prescribers in San Francisco, CA | 43 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 21 payments worth $1,979 in total to this clinician.
| Edwards Lifesciences Corporation | $1,366 |
|---|---|
| Abbott Laboratories | $266 |
| Abiomed | $125 |
| Teleflex LLC | $59.76 |
| Paragonix Technologies, Inc. | $43.88 |
| Novo Nordisk Inc | $32.45 |
| Pfizer Inc. | $30.62 |
| Alnylam Pharmaceuticals Inc. | $28.30 |
| Travel and Lodging | $1,359 |
|---|---|
| Food and Beverage | $620 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Edwards Lifesciences Corporation Jun 2, 2025 | Travel and Lodging travel to Newark, NJ · in-kind | $663 |
| Edwards Lifesciences Corporation Jun 23, 2025 | Travel and Lodging travel to New York, NY · in-kind | $398 |
| Edwards Lifesciences Corporation Jun 25, 2025 | Travel and Lodging travel to New York, NY · in-kind | $190 |
| Edwards Lifesciences Corporation Jun 24, 2025 | Travel and Lodging travel to New York, NY · in-kind | $91.14 |
| Edwards Lifesciences Corporation Jun 24, 2025 | Travel and Lodging travel to New York, NY | $16.95 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $12,206 in research payments for these studies, mostly to the institutions running them.
- Dapagliflozin in Acute Decompensated Heart Failure
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.